Skip to content

Efficacy and safety of alfentanil and propofol in paediatric upper endoscopy: a double-blind randomized trial

Efficacy and safety of alfentanil and propofol in paediatric upper endoscopy: a double-blind randomized trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066584
Enrollment
Unknown
Registered
2022-12-09
Start date
2022-08-23
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anesthesia at remote locations

Interventions

A1:I.V. alfentanil 7mcg/kg
A2:I.V. alfentanil 10mcg/kg
A3:I.V. alfentanil 15mcg/kg

Sponsors

GUANGZHOU WOMEN AND CHILDRENS MEDICAL CENTER
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1 Both the children and their legal guardians signed the informed consent 2 A painless gastroscopy was performe 3 ASA ?~?;age:8 to 12 years old

Exclusion criteria

Exclusion criteria: (1) Drug allergy in this study; (2) Accompanied by cardiovascular and respiratory diseases, severe liver and kidney diseases; (3) A child with a wirh mental illness; (4) A child with a heart disease or having heart surgery.

Design outcomes

Primary

MeasureTime frame
Incidence of movement;

Countries

China

Contacts

Public ContactYonghong Tan

Guangzhou Women and Children's Medical Center

759929121@qq.com+86 13808880921

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026